These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 2888454)

  • 1. Increased plasma free cortisol in ocular hypertension and open angle glaucoma.
    Schwartz B; McCarty G; Rosner B
    Arch Ophthalmol; 1987 Aug; 105(8):1060-5. PubMed ID: 2888454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased response of plasma cortisol to intravenous metyrapone in ocular hypertension and primary open-angle glaucoma.
    Schwartz B; Wysocki A; Qi Y
    J Glaucoma; 2005 Dec; 14(6):474-81. PubMed ID: 16276280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased plasma noncortisol glucocorticoid activity in open-angle glaucoma.
    McCarty GR; Schwartz B
    Invest Ophthalmol Vis Sci; 1991 Apr; 32(5):1600-8. PubMed ID: 2016141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced plasma cortisol binding to albumin in ocular hypertension and primary open-angle glaucoma.
    McCarty GR; Schwartz B
    Curr Eye Res; 1999 Jun; 18(6):467-76. PubMed ID: 10435834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased plasma cortisol in response to intramuscular ACTH in ocular hypertensives and primary open-angle glaucomas.
    Schwartz B; Rabin PA; Wysocki A; Martin J
    J Glaucoma; 2007 May; 16(3):282-6. PubMed ID: 17438420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of carteolol and timolol on plasma lipid profiles in older women with ocular hypertension or primary open-angle glaucoma.
    Stewart WC; Dubiner HB; Mundorf TK; Laibovitz RA; Sall KN; Katz LJ; Singh K; Shulman DG; Siegel LI; Hudgins AC; Nussbaum L; Apostolaros M
    Am J Ophthalmol; 1999 Feb; 127(2):142-7. PubMed ID: 10030554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased plasma cortisol levels in ocular hypertension.
    Schwartz B; Seddon JM
    Arch Ophthalmol; 1981 Oct; 99(10):1791-4. PubMed ID: 7295128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of the beta-adrenergic-blocking agents, timolol and carteolol, on plasma lipids and lipoproteins in Japanese glaucoma patients.
    Yamamoto T; Kitazawa Y; Noma A; Maeda S; Kato A; Ando Y; Ido T; Inazumi K; Hayakawa T; Goto Y; Ichien M
    J Glaucoma; 1996 Aug; 5(4):252-7. PubMed ID: 8795770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hormonal changes in open-angle glaucoma. II. Levels of cortisol and somatotropin in serum].
    Janousková K; Tĕsínský P; Topolcan O
    Cesk Oftalmol; 1993 Jan; 49(1):22-9. PubMed ID: 8458087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood viscosity in ocular hypertension.
    Garcia-Salinas P; Trope GE; Glynn M
    Can J Ophthalmol; 1988 Dec; 23(7):305-7. PubMed ID: 3228777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tafluprost/Timolol: A Review in Open-Angle Glaucoma or Ocular Hypertension.
    Hoy SM
    Drugs; 2015 Oct; 75(15):1807-13. PubMed ID: 26431840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of ocular blood flow in untreated primary open-angle glaucoma and ocular hypertension.
    Kerr J; Nelson P; O'Brien C
    Am J Ophthalmol; 1998 Jul; 126(1):42-51. PubMed ID: 9683148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigation into the vasospastic mechanisms in the pathogenesis of glaucomatous neuropathy.
    Terelak-Borys B; Czechowicz-Janicka K
    Klin Oczna; 2011; 113(7-9):201-8. PubMed ID: 22256559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Total cholesterol and high-density lipoprotein levels as risk factors for increased intraocular pressure.
    Stewart WC; Sine C; Sutherland S; Stewart JA
    Am J Ophthalmol; 1996 Oct; 122(4):575-7. PubMed ID: 8862057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conjunctival modifications in ocular hypertension and primary open angle glaucoma: an in vivo confocal microscopy study.
    Ciancaglini M; Carpineto P; Agnifili L; Nubile M; Fasanella V; Mastropasqua L
    Invest Ophthalmol Vis Sci; 2008 Jul; 49(7):3042-8. PubMed ID: 18316705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brimonidine. A review of its pharmacological properties and clinical potential in the management of open-angle glaucoma and ocular hypertension.
    Adkins JC; Balfour JA
    Drugs Aging; 1998 Mar; 12(3):225-41. PubMed ID: 9534022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-1beta tear concentration in glaucomatous and ocular hypertensive patients treated with preservative-free nonselective beta-blockers.
    Manni G; Centofanti M; Oddone F; Parravano M; Bucci MG
    Am J Ophthalmol; 2005 Jan; 139(1):72-7. PubMed ID: 15652830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Latanoprost : an update of its use in glaucoma and ocular hypertension.
    Perry CM; McGavin JK; Culy CR; Ibbotson T
    Drugs Aging; 2003; 20(8):597-630. PubMed ID: 12795627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peripapillary Choroidal Thickness and Choroidal Area in Glaucoma, Ocular Hypertension and Healthy Subjects by SD-OCT.
    Lamparter J; Schulze A; Riedel J; Wasielica-Poslednik J; König J; Pfeiffer N; Hoffmann EM
    Klin Monbl Augenheilkd; 2015 Apr; 232(4):390-4. PubMed ID: 25902084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered peripheral sensitivity to glucocorticoids in primary open-angle glaucoma.
    Stokes J; Walker BR; Campbell JC; Seckl JR; O'Brien C; Andrew R
    Invest Ophthalmol Vis Sci; 2003 Dec; 44(12):5163-7. PubMed ID: 14638712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.